11/06/2025
The FDA has sent warning letters to 18 websites for illegally marketing and selling counterfeit or unapproved versions of botulinum toxin and similar injectable products following reports of adverse events associated with the products. ASDSA encourages patients to ensure medical procedures use FDA-approved products and are performed or supervised by an onsite physician, especially by a board certified dermatologist. Visit https://bit.ly/4eyw60g to learn more.